Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.
Vincent J GnanapragasamTristan BarrettVineetha ThankapannairDavid R ThurtleJose Rubio-BrionesJose Domínguez-EscrigOla BrattPar StatinKenneth MuirArtitaya LophatananonPublished in: BJU international (2019)
Using disease prognosis allows a rational approach to inclusion criteria, discontinuation triggers and risk-stratified management in AS.
Keyphrases